Global Cell and Gene Therapy Manufacturing QC Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 125
Published Date: 08 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Cell and Gene Therapy Manufacturing QC market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cell and Gene Therapy Manufacturing QC industry chain, the market status of Precision Therapy (Safety Testing, Purity Testing), Biological Research (Safety Testing, Purity Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Manufacturing QC.
Regionally, the report analyzes the Cell and Gene Therapy Manufacturing QC markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Manufacturing QC market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Manufacturing QC market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Manufacturing QC industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Safety Testing, Purity Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Manufacturing QC market.
Regional Analysis: The report involves examining the Cell and Gene Therapy Manufacturing QC market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Manufacturing QC market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell and Gene Therapy Manufacturing QC:
Company Analysis: Report covers individual Cell and Gene Therapy Manufacturing QC players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy Manufacturing QC This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Precision Therapy, Biological Research).
Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Manufacturing QC. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Manufacturing QC areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Manufacturing QC market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cell and Gene Therapy Manufacturing QC market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Safety Testing
Purity Testing
Potency Testing
Identity Testing
Stability Testing
Market segment by Application
Precision Therapy
Biological Research
Market segment by players, this report covers
Bio-Techne Corporation
BioMerieux SA
Catalent, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Intertek Group plc
Lonza Group AG
Merck KGaA
Sartorius AG
SGS S.A.
Sistemic Scotland Limited
Thermo Fisher Scientific Inc.
Vigene Biosciences, Inc.
WuXi AppTec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Manufacturing QC product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Manufacturing QC, with revenue, gross margin and global market share of Cell and Gene Therapy Manufacturing QC from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy Manufacturing QC competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy Manufacturing QC market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Manufacturing QC.
Chapter 13, to describe Cell and Gene Therapy Manufacturing QC research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Manufacturing QC
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Manufacturing QC by Type
1.3.1 Overview: Global Cell and Gene Therapy Manufacturing QC Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type in 2023
1.3.3 Safety Testing
1.3.4 Purity Testing
1.3.5 Potency Testing
1.3.6 Identity Testing
1.3.7 Stability Testing
1.4 Global Cell and Gene Therapy Manufacturing QC Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Manufacturing QC Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Precision Therapy
1.4.3 Biological Research
1.5 Global Cell and Gene Therapy Manufacturing QC Market Size & Forecast
1.6 Global Cell and Gene Therapy Manufacturing QC Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Manufacturing QC Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cell and Gene Therapy Manufacturing QC Market Size by Region, (2019-2030)
1.6.3 North America Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2019-2030)
1.6.4 Europe Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2019-2030)
1.6.6 South America Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2019-2030)
2.1 Bio-Techne Corporation
2.1.1 Bio-Techne Corporation Details
2.1.2 Bio-Techne Corporation Major Business
2.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product and Solutions
2.1.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bio-Techne Corporation Recent Developments and Future Plans
2.2 BioMerieux SA
2.2.1 BioMerieux SA Details
2.2.2 BioMerieux SA Major Business
2.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Product and Solutions
2.2.4 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMerieux SA Recent Developments and Future Plans
2.3 Catalent, Inc.
2.3.1 Catalent, Inc. Details
2.3.2 Catalent, Inc. Major Business
2.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
2.3.4 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Catalent, Inc. Recent Developments and Future Plans
2.4 Charles River Laboratories International Inc.
2.4.1 Charles River Laboratories International Inc. Details
2.4.2 Charles River Laboratories International Inc. Major Business
2.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
2.4.4 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Charles River Laboratories International Inc. Recent Developments and Future Plans
2.5 Eurofins Scientific SE
2.5.1 Eurofins Scientific SE Details
2.5.2 Eurofins Scientific SE Major Business
2.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product and Solutions
2.5.4 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eurofins Scientific SE Recent Developments and Future Plans
2.6 F. Hoffmann-La Roche Ltd
2.6.1 F. Hoffmann-La Roche Ltd Details
2.6.2 F. Hoffmann-La Roche Ltd Major Business
2.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product and Solutions
2.6.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.7 Intertek Group plc
2.7.1 Intertek Group plc Details
2.7.2 Intertek Group plc Major Business
2.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Product and Solutions
2.7.4 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Intertek Group plc Recent Developments and Future Plans
2.8 Lonza Group AG
2.8.1 Lonza Group AG Details
2.8.2 Lonza Group AG Major Business
2.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Product and Solutions
2.8.4 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lonza Group AG Recent Developments and Future Plans
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business
2.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Product and Solutions
2.9.4 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck KGaA Recent Developments and Future Plans
2.10 Sartorius AG
2.10.1 Sartorius AG Details
2.10.2 Sartorius AG Major Business
2.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Product and Solutions
2.10.4 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sartorius AG Recent Developments and Future Plans
2.11 SGS S.A.
2.11.1 SGS S.A. Details
2.11.2 SGS S.A. Major Business
2.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Product and Solutions
2.11.4 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 SGS S.A. Recent Developments and Future Plans
2.12 Sistemic Scotland Limited
2.12.1 Sistemic Scotland Limited Details
2.12.2 Sistemic Scotland Limited Major Business
2.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product and Solutions
2.12.4 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sistemic Scotland Limited Recent Developments and Future Plans
2.13 Thermo Fisher Scientific Inc.
2.13.1 Thermo Fisher Scientific Inc. Details
2.13.2 Thermo Fisher Scientific Inc. Major Business
2.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
2.13.4 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.14 Vigene Biosciences, Inc.
2.14.1 Vigene Biosciences, Inc. Details
2.14.2 Vigene Biosciences, Inc. Major Business
2.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
2.14.4 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Vigene Biosciences, Inc. Recent Developments and Future Plans
2.15 WuXi AppTec
2.15.1 WuXi AppTec Details
2.15.2 WuXi AppTec Major Business
2.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Product and Solutions
2.15.4 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 WuXi AppTec Recent Developments and Future Plans
3.1 Global Cell and Gene Therapy Manufacturing QC Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cell and Gene Therapy Manufacturing QC by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Manufacturing QC Players Market Share in 2023
3.2.3 Top 6 Cell and Gene Therapy Manufacturing QC Players Market Share in 2023
3.3 Cell and Gene Therapy Manufacturing QC Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Manufacturing QC Market: Region Footprint
3.3.2 Cell and Gene Therapy Manufacturing QC Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Manufacturing QC Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Cell and Gene Therapy Manufacturing QC Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cell and Gene Therapy Manufacturing QC Market Forecast by Type (2025-2030)
5.1 Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2019-2024)
5.2 Global Cell and Gene Therapy Manufacturing QC Market Forecast by Application (2025-2030)
6.1 North America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2030)
6.2 North America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2030)
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
6.3.1 North America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2030)
6.3.2 United States Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
6.3.3 Canada Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
6.3.4 Mexico Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
7.1 Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2030)
7.2 Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2030)
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
7.3.1 Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2030)
7.3.2 Germany Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
7.3.3 France Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
7.3.5 Russia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
7.3.6 Italy Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2019-2030)
8.3.2 China Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
8.3.3 Japan Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
8.3.4 South Korea Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
8.3.5 India Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
8.3.7 Australia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
9.1 South America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2030)
9.2 South America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2030)
9.3 South America Cell and Gene Therapy Manufacturing QC Market Size by Country
9.3.1 South America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2030)
9.3.2 Brazil Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
9.3.3 Argentina Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2030)
10.3.2 Turkey Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
10.3.4 UAE Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2019-2030)
11.1 Cell and Gene Therapy Manufacturing QC Market Drivers
11.2 Cell and Gene Therapy Manufacturing QC Market Restraints
11.3 Cell and Gene Therapy Manufacturing QC Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Cell and Gene Therapy Manufacturing QC Industry Chain
12.2 Cell and Gene Therapy Manufacturing QC Upstream Analysis
12.3 Cell and Gene Therapy Manufacturing QC Midstream Analysis
12.4 Cell and Gene Therapy Manufacturing QC Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bio-Techne Corporation Company Information, Head Office, and Major Competitors
Table 6. Bio-Techne Corporation Major Business
Table 7. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 8. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bio-Techne Corporation Recent Developments and Future Plans
Table 10. BioMerieux SA Company Information, Head Office, and Major Competitors
Table 11. BioMerieux SA Major Business
Table 12. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 13. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioMerieux SA Recent Developments and Future Plans
Table 15. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 16. Catalent, Inc. Major Business
Table 17. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 18. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Catalent, Inc. Recent Developments and Future Plans
Table 20. Charles River Laboratories International Inc. Company Information, Head Office, and Major Competitors
Table 21. Charles River Laboratories International Inc. Major Business
Table 22. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 23. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Charles River Laboratories International Inc. Recent Developments and Future Plans
Table 25. Eurofins Scientific SE Company Information, Head Office, and Major Competitors
Table 26. Eurofins Scientific SE Major Business
Table 27. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 28. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Eurofins Scientific SE Recent Developments and Future Plans
Table 30. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Ltd Major Business
Table 32. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 33. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Table 35. Intertek Group plc Company Information, Head Office, and Major Competitors
Table 36. Intertek Group plc Major Business
Table 37. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 38. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Intertek Group plc Recent Developments and Future Plans
Table 40. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 41. Lonza Group AG Major Business
Table 42. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 43. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Lonza Group AG Recent Developments and Future Plans
Table 45. Merck KGaA Company Information, Head Office, and Major Competitors
Table 46. Merck KGaA Major Business
Table 47. Merck KGaA Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 48. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Merck KGaA Recent Developments and Future Plans
Table 50. Sartorius AG Company Information, Head Office, and Major Competitors
Table 51. Sartorius AG Major Business
Table 52. Sartorius AG Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 53. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sartorius AG Recent Developments and Future Plans
Table 55. SGS S.A. Company Information, Head Office, and Major Competitors
Table 56. SGS S.A. Major Business
Table 57. SGS S.A. Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 58. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. SGS S.A. Recent Developments and Future Plans
Table 60. Sistemic Scotland Limited Company Information, Head Office, and Major Competitors
Table 61. Sistemic Scotland Limited Major Business
Table 62. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 63. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Sistemic Scotland Limited Recent Developments and Future Plans
Table 65. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 66. Thermo Fisher Scientific Inc. Major Business
Table 67. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 68. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 70. Vigene Biosciences, Inc. Company Information, Head Office, and Major Competitors
Table 71. Vigene Biosciences, Inc. Major Business
Table 72. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 73. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Vigene Biosciences, Inc. Recent Developments and Future Plans
Table 75. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 76. WuXi AppTec Major Business
Table 77. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product and Solutions
Table 78. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. WuXi AppTec Recent Developments and Future Plans
Table 80. Global Cell and Gene Therapy Manufacturing QC Revenue (USD Million) by Players (2019-2024)
Table 81. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Players (2019-2024)
Table 82. Breakdown of Cell and Gene Therapy Manufacturing QC by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Cell and Gene Therapy Manufacturing QC, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Cell and Gene Therapy Manufacturing QC Players
Table 85. Cell and Gene Therapy Manufacturing QC Market: Company Product Type Footprint
Table 86. Cell and Gene Therapy Manufacturing QC Market: Company Product Application Footprint
Table 87. Cell and Gene Therapy Manufacturing QC New Market Entrants and Barriers to Market Entry
Table 88. Cell and Gene Therapy Manufacturing QC Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Cell and Gene Therapy Manufacturing QC Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Cell and Gene Therapy Manufacturing QC Consumption Value Share by Type (2019-2024)
Table 91. Global Cell and Gene Therapy Manufacturing QC Consumption Value Forecast by Type (2025-2030)
Table 92. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2024)
Table 93. Global Cell and Gene Therapy Manufacturing QC Consumption Value Forecast by Application (2025-2030)
Table 94. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Cell and Gene Therapy Manufacturing QC Raw Material
Table 125. Key Suppliers of Cell and Gene Therapy Manufacturing QC Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing QC Picture
Figure 2. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type in 2023
Figure 4. Safety Testing
Figure 5. Purity Testing
Figure 6. Potency Testing
Figure 7. Identity Testing
Figure 8. Stability Testing
Figure 9. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application in 2023
Figure 11. Precision Therapy Picture
Figure 12. Biological Research Picture
Figure 13. Global Cell and Gene Therapy Manufacturing QC Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Cell and Gene Therapy Manufacturing QC Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Cell and Gene Therapy Manufacturing QC Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Region in 2023
Figure 18. North America Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Players in 2023
Figure 24. Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Cell and Gene Therapy Manufacturing QC Market Share in 2023
Figure 26. Global Top 6 Players Cell and Gene Therapy Manufacturing QC Market Share in 2023
Figure 27. Global Cell and Gene Therapy Manufacturing QC Consumption Value Share by Type (2019-2024)
Figure 28. Global Cell and Gene Therapy Manufacturing QC Market Share Forecast by Type (2025-2030)
Figure 29. Global Cell and Gene Therapy Manufacturing QC Consumption Value Share by Application (2019-2024)
Figure 30. Global Cell and Gene Therapy Manufacturing QC Market Share Forecast by Application (2025-2030)
Figure 31. North America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 41. France Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Region (2019-2030)
Figure 48. China Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 51. India Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Cell and Gene Therapy Manufacturing QC Consumption Value (2019-2030) & (USD Million)
Figure 65. Cell and Gene Therapy Manufacturing QC Market Drivers
Figure 66. Cell and Gene Therapy Manufacturing QC Market Restraints
Figure 67. Cell and Gene Therapy Manufacturing QC Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Manufacturing QC in 2023
Figure 70. Manufacturing Process Analysis of Cell and Gene Therapy Manufacturing QC
Figure 71. Cell and Gene Therapy Manufacturing QC Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bio-Techne Corporation BioMerieux SA Catalent, Inc. Charles River Laboratories International Inc. Eurofins Scientific SE F. Hoffmann-La Roche Ltd Intertek Group plc Lonza Group AG Merck KGaA Sartorius AG SGS S.A. Sistemic Scotland Limited Thermo Fisher Scientific Inc. Vigene Biosciences, Inc. WuXi AppTec
11 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
